Rare but serious risks include: Pancreatitis : Severe abdominal pain should prompt immediate medical attention Gallbladder problems : Rapid weight loss can increase gallstone risk Diabetic retinopathy complications : In people with existing eye disease, rapid glucose improvement may temporarily worsen retinopathy, particularly with semaglutide [14] [15] Hypoglycaemia : Low blood sugar is uncommon with GLP-1 agonists alone but can occur if combined with insulin or sulphonylureas [17] [18] GLP-1 agonists are not recognised to directly cause dangerous blood pressure drops (hypotension) in most patients
Grow your brand, now and through patent expiry This blog is part of an ongoing series, A Brave New World: Therapeutic Area Deep Dives
The effect of semaglutide subcutaneous injection at 2.4 mg per week in patients with HFpEF and obesity (BMI 30 kg/m 2 ) but without diabetes was tested in STEP-HFpEF [29]
For those who enjoy alcohol on weekends, our guide on alcohol and GLP-1 medication interactions provides important context on how timing intersects with social drinking
But its natural release into the bloodstream is fleeting
In practice the medication line is the dominant cost, and that line is set by the compound and the dispensing pharmacy rather than by anything you type at checkout
